| Year |
Citation |
Score |
| 2021 |
Scheinman SB, Zaldua S, Dada A, Krochmaliuk K, Dye K, Marottoli FM, Thatcher GRJ, Tai LM. Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human . Frontiers in Neuroscience. 15: 628403. PMID 33642985 DOI: 10.3389/fnins.2021.628403 |
0.397 |
|
| 2021 |
Tai LM, Maldonado Weng J, LaDu MJ, Brady ST. Relevance of transgenic mouse models for Alzheimer's disease. Progress in Molecular Biology and Translational Science. 177: 1-48. PMID 33453936 DOI: 10.1016/bs.pmbts.2020.07.007 |
0.32 |
|
| 2020 |
Zaldua S, Damen FC, Pisharody R, Thomas R, Fan KD, Ekkurthi GK, Scheinman SB, Alahmadi S, Marottoli FM, Alford S, Cai K, Tai LM. Epidermal growth factor treatment of female mice that express at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction. Heliyon. 6: e03919. PMID 32478184 DOI: 10.1016/J.Heliyon.2020.E03919 |
0.498 |
|
| 2017 |
Marottoli FM, Katsumata Y, Koster KP, Thomas R, Fardo DW, Tai LM. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction. Asn Neuro. 9: 1759091417719201. PMID 28707482 DOI: 10.1177/1759091417719201 |
0.344 |
|
| 2017 |
Thomas R, Morris AWJ, Tai LM. Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice. Heliyon. 3: e00319. PMID 28626809 DOI: 10.1016/j.heliyon.2017.e00319 |
0.341 |
|
| 2017 |
Tai LM, Balu D, Avila-Munoz E, Abdullah L, Thomas R, Collins N, Valencia-Olvera AC, LaDu MJ. EFAD Transgenic Mice as a Human APOE Relevant Preclinical Model of Alzheimer's Disease. Journal of Lipid Research. PMID 28389477 DOI: 10.1194/jlr.R076315 |
0.334 |
|
| 2016 |
Thomas R, Zuchowska P, Morris AW, Marottoli FM, Sunny S, Deaton R, Gann PH, Tai LM. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. Acta Neuropathologica Communications. 4: 111. PMID 27788676 DOI: 10.1186/s40478-016-0387-3 |
0.358 |
|
| 2015 |
Liu DS, Pan XD, Zhang J, Shen H, Collins NC, Cole AM, Koster KP, Ben Aissa M, Dai XM, Zhou M, Tai LM, Zhu YG, LaDu M, Chen XC. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Molecular Neurodegeneration. 10: 7. PMID 25871877 DOI: 10.1186/s13024-015-0002-2 |
0.376 |
|
| 2015 |
Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, Van Eldik LJ, LaDu MJ. APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective. Journal of Neurochemistry. 133: 465-88. PMID 25689586 DOI: 10.1111/jnc.13072 |
0.334 |
|
| 2012 |
Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW, Weeber EJ, Bu G, Yu C, Ladu MJ. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. The Journal of Biological Chemistry. 287: 41774-86. PMID 23060451 DOI: 10.1074/Jbc.M112.407957 |
0.328 |
|
| 2012 |
Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, LaDu MJ. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 60: 559-69. PMID 22228589 DOI: 10.1002/Glia.22289 |
0.329 |
|
| Show low-probability matches. |